Topic_Solicitation_No._2_70RWMD19R00000005_Amendment_3_Pitch_Paper_Q_and_A.pdf

PDF 119 KB Posted

Attached to
CWMD 5-Year Research and Development (R&D) Open Broad Agency Announcement (OBAA) 70RDND19R00000003 and Topic Solicitations
Solicitation number
70RDND19R00000003
Issued by

About this file

This document provides details regarding an open broad agency announcement and topic solicitation from the Department of Homeland Security to support countering weapons of mass destruction research and development. The opportunity includes a five-year research and development program seeking innovative solutions for preventing, protecting against, responding to, and mitigating nuclear, chemical, radiological, and biological threats. Technology readiness levels of 1-7 will be considered for chemical, biological, radiological, and nuclear threats. Interested offerors should monitor for future topic solicitations that will be issued as amendments throughout the five-year period and provide additional submission details. The first topic solicitation is included as an attachment with a planned industry day on May 1, 2019 and pitch paper and proposal deadlines to be specified. Questions may be directed to the provided email.

Topic Solicitation No. 2 70RWMD19R00000005 Amendment 3 Pitch Paper Q&A

View the file

Other files

File Type Posted
Topic Soliciatation 2 Updated Dates.pdf PDF
Proposal Q and A Topic Solicitation No. 2 70RWMD19R00000005.pdf PDF
Topic_Solicitation_No._2_70RWMD19R00000005_Amendment_2.pdf PDF
Topic_Solicitation_No._2_70RWMD19R00000005_Amendment_1.pdf PDF
Attachment_6_Engility_NDA_for_Topic_Solicitation_70RDND19R00000005.pdf PDF
Attachment_2_CWMD_Research_and_Development_5_Year_OBAA_Final.pdf PDF
Attachment_3_Clauses_for_Firm_Fixed_Price.pdf PDF
Attachment_5_Gryphon_Schafer_NDA_Topic_Solicitation_70RDND19R0000005.pdf PDF
Attachment_8_R&D_SOW_RandD_Contracts_Template.doc DOC document
70RWMD19R00000005_SF_33.pdf PDF
Attachment_7_IAA_SOW_template.docx DOCX document
Attachment_1_CWMD_RD_OBA_Topic_Solicitation_Chem_Bio_Standoff-20190916.pdf PDF
Attachment_4_Clauses_for_Cost_Plust_Fixed_Fee.pdf PDF
OBAA_Solicitation_No._70RDND19R00000003_Amendment.pdf PDF
QandAs_for_Topic_Sol._No._1_70RDND19R00000004_-_Proposals.pdf PDF
Topic_Solicitation_No._1_70RDND19R00000004_Amendment.docx DOCX document
QandAs_for_CWMD_OBAA_-_SmartCities_Pitch_Papers.pdf PDF
CWMD_RD_Open_BAA_IndustryDayQ&As_20190502.pdf PDF
CWMD_RD_Open_BAA_Industry_Day_Attendee_List_20190501.pdf PDF
RD_OBAA_Industry_Day_Slides_Final_20190501.pdf PDF
Gryphon_Schafer_NDA_Topic_Solicitation_70RDND19R0000004.pdf PDF
SOW_RandD_Template.doc DOC document
Engility_NDA_for_Topic_Solicitation_70RDND19R00000004.pdf PDF
CWMD_Research_and_Development_5_Year_OBAA_Final.pdf PDF
Show all 24

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Amendment 3

Questions for CWMD OBAA Topic Solicitation No. 2: 70RWMD19R00000005 Pitch Papers

Question

Reference Contractor’s Question Answer

1 Topic Solicitation No 2:

70RWMD19R00000005, Page 3 bottom, Item 2. Be used to provide a “perimeter” of detection and identification capability for chemical and/or biological agents around a stadium or large public gathering.

For the perimeter/stadium detection and ID of chemical and bio agents, are vapor and/or aerosol releases considered as part of the threat space that CWMD is looking to address?

For chemical agents, any form of release, to include vapor and aerosol, is of interest.

For biological agents, aerosol release is recommended.

2 General To what extent is the agency interested in a proposed single-technology solution which is expected to meet some threat class detection goals (e.g. nerve agents) with moderate risk and others (e.g. viruses) with high risk? What weighting scheme does the Government plan for evaluating proposals with respect to this kind of tradeoff?

The agency is interested in any proposed solutions to meet the objectives of the Topic Solicitation. Pitch papers will be reviewed in accordance with Section

5.2.3 of the OBAA.

3 General Will the Government provide any access to test facilities and test materials, or should performers budget to obtain access to test facilities and materials?

The Government will provide access to test facilities and materials for final demonstration only. Performers should budget to obtain access to test facilities and materials for other demonstrations.

4 General For each phase (I, II, III) what types of samples are considered suitable for demonstrating success? For instance, can Phase I be executed with simulants? Phase II?

Phase I can be executed with simulants. Phase II and III should be executed with a combination of simulants and relevant chemical and biological agents.

File details come from the government source that posted it. Updated .